Jose Carlos Jaime-Perez
Overview
Explore the profile of Jose Carlos Jaime-Perez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reassessing blood product irradiation in haploidentical transplantation: a single-center perspective
Martinez-Hernandez J, Lopez-Mora Y, Salazar-Riojas R, Alvarado Navarro D, Hernandez-Navarro A, Chavez-Estrada Y, et al.
Hematology
. 2024 Oct;
29(1):2420144.
PMID: 39466074
Objectives: The main objective was to investigate the incidence of transfusion-associated graft-versus-host disease (TA-GVHD) in patients who underwent haploidentical hematopoietic cell transplants (HCT) and received non-irradiated leukoreduced blood components. The...
2.
Jaime-Perez J, Valdespino-Valdes J, Gomez-De Leon A, Barragan-Longoria R, Dominguez-Villanueva A, Cantu-Rodriguez O, et al.
Front Immunol
. 2024 Oct;
15:1400610.
PMID: 39430740
Background: Hematopoietic cell transplantation (HCT) increases survival for acute leukemia. Outpatient allogeneic HCT reduces costs and increases transplant rates in developing countries. We report outcomes of outpatient HLA-identical and haploidentical...
3.
Cantu-Rodriguez O, Hawing-Zarate J, Dorsey-Trevino E, Hernandez-Barajas D, Villalobos-Gutierrez L, Jaime-Perez J, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39337084
: The lactate/pyruvate (LP) ratio has been studied as an alternative to serum lactate to determine clinical prognosis. Despite its clinical utility, there is a paucity of evidence evaluating the...
4.
Jaime-Perez J, Gonzalez-Trevino M, Gomez-De Leon A, Campos-Bocardo M, Barragan-Longoria R, Cantu-Rodriguez O, et al.
Blood Cells Mol Dis
. 2024 Sep;
110:102886.
PMID: 39243657
No abstract available.
5.
Jaime-Perez J, Gonzalez-Trevino M, Gomez-De Leon A, Campos-Bocardo M, Barragan-Longoria R, Cantu-Rodriguez O, et al.
Blood Cells Mol Dis
. 2024 Aug;
109:102885.
PMID: 39182343
Objective: To document the results of outpatient hematopoietic stem cell transplantation (HSCT) from the peripheral blood (PB) of sibling donors without anti-thymocyte globulin (ATG) in the conditioning regimen. Material And...
6.
Jaime-Perez J, Hernandez-Coronado M, Gonzalez-Trevino M, Barragan-Longoria R, Ramos-Davila E, Gomez-Almaguer D
Hematol Oncol
. 2024 Apr;
42(3):e3271.
PMID: 38606890
No abstract available.
7.
Jaime-Perez J, Melendez-Flores J, Valdespino-Valdes J, Gomez-De Leon A, Colunga-Pedraza P, Gutierrez-Aguirre C, et al.
Expert Rev Hematol
. 2024 Jan;
17(1-3):77-86.
PMID: 38226642
Background: HLA compatibility predicts allogeneic hematopoietic cell transplant (allo-HCT) and graft-versus-host disease (GvHD) outcomes. There is insufficient information regarding GvHD outcomes for outpatient HLA-identical and haploidentical-HCT employing reduced-intensity conditioning (RIC)....
8.
Cantu-Rodriguez O, Osorno-Rodriguez K, Dorsey-Trevino E, Gutierrez-Aguirre C, Jaime-Perez J, Gomez-Villarreal J, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Aug;
23(11):e386-e392.
PMID: 37625952
Background: While second-generation tyrosine kinase inhibitors (TKI) revolutionized treatment for patients with chronic myeloid leukemia (CML) who developed a suboptimal response to imatinib, many patients in developing countries are fixed...
9.
Noyola-Perez A, Gil-Flores L, Martinez-Espinosa H, Ramos-Barrera E, Rodriguez-Gonzalez V, Sung L, et al.
Lancet Haematol
. 2023 Mar;
10(4):e246-e247.
PMID: 36990621
No abstract available.
10.
Jaime-Perez J, Melendez-Flores J, Ramos-Davila E, Gutierrez-Aguirre C, Cantu-Rodriguez O, Marfil-Rivera L, et al.
Clin Transplant
. 2023 Mar;
37(6):e14972.
PMID: 36943871
Background: Despite the improvements in supportive care for allogeneic-hematopoietic cell transplantation (allo-HCT) recipients, infectious complications and infection-related mortality (IRM) continue to be a major issue for transplantation centers. Methods: We...